BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 29449054)

  • 1. Second generation antipsychotic-induced mitochondrial alterations: Implications for increased risk of metabolic syndrome in patients with schizophrenia.
    Scaini G; Quevedo J; Velligan D; Roberts DL; Raventos H; Walss-Bass C
    Eur Neuropsychopharmacol; 2018 Mar; 28(3):369-380. PubMed ID: 29449054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic adverse effects of olanzapine on cognitive dysfunction: A possible relationship between BDNF and TNF-alpha.
    Zhang C; Fang X; Yao P; Mao Y; Cai J; Zhang Y; Chen M; Fan W; Tang W; Song L
    Psychoneuroendocrinology; 2017 Jul; 81():138-143. PubMed ID: 28477447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between SCAP and SREBF1 gene polymorphisms and metabolic syndrome in schizophrenia patients treated with atypical antipsychotics.
    Yang L; Chen J; Li Y; Wang Y; Liang S; Shi Y; Shi S; Xu Y
    World J Biol Psychiatry; 2016 Sep; 17(6):467-74. PubMed ID: 26982812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolomic profiling of schizophrenia patients at risk for metabolic syndrome.
    Paredes RM; Quinones M; Marballi K; Gao X; Valdez C; Ahuja SS; Velligan D; Walss-Bass C
    Int J Neuropsychopharmacol; 2014 Aug; 17(8):1139-48. PubMed ID: 24565079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Typical and atypical antipsychotics differentially affect long-term incidence rates of the metabolic syndrome in first-episode patients with schizophrenia: a retrospective chart review.
    De Hert M; Schreurs V; Sweers K; Van Eyck D; Hanssens L; Sinko S; Wampers M; Scheen A; Peuskens J; van Winkel R
    Schizophr Res; 2008 Apr; 101(1-3):295-303. PubMed ID: 18299188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clozapine use and sedentary lifestyle as determinants of metabolic syndrome in outpatients with schizophrenia.
    Eskelinen S; Sailas E; Joutsenniemi K; Holi M; Suvisaari J
    Nord J Psychiatry; 2015 Jul; 69(5):339-45. PubMed ID: 25981178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement 3 and metabolic syndrome induced by clozapine: a cross-sectional study and retrospective cohort analysis.
    Zhang C; Zhang Y; Cai J; Chen M; Song L
    Pharmacogenomics J; 2017 Jan; 17(1):92-97. PubMed ID: 26503818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perturbation in mitochondrial network dynamics and in complex I dependent cellular respiration in schizophrenia.
    Rosenfeld M; Brenner-Lavie H; Ari SG; Kavushansky A; Ben-Shachar D
    Biol Psychiatry; 2011 May; 69(10):980-8. PubMed ID: 21397211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TNF-α -308 G>A polymorphism and weight gain in patients with schizophrenia under long-term clozapine, risperidone or olanzapine treatment.
    Huang HH; Wang YC; Wu CL; Hong CJ; Bai YM; Tsai SJ; Liou YJ
    Neurosci Lett; 2011 Oct; 504(3):277-80. PubMed ID: 21967963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for a mitochondrial oxidative phosphorylation defect in brains from patients with schizophrenia.
    Maurer I; Zierz S; Möller H
    Schizophr Res; 2001 Mar; 48(1):125-36. PubMed ID: 11278159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic syndrome in schizophrenia - who is more to blame: FGA polypharmacy or clozapine monotherapy?
    Softic R; Sutovic A; Avdibegovic E; Osmanović E; Bećirović E; Hajdukov MM
    Psychiatr Danub; 2015 Dec; 27(4):378-84. PubMed ID: 26609650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melatonin inhibits rotenone-induced SH-SY5Y cell death via the downregulation of Dynamin-Related Protein 1 expression.
    Zhou H; Cheang T; Su F; Zheng Y; Chen S; Feng J; Pei Z; Chen L
    Eur J Pharmacol; 2018 Jan; 819():58-67. PubMed ID: 29183837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Latent Toxoplasma gondii infection is associated with decreased serum triglyceride to high-density lipoprotein cholesterol ratio in male patients with schizophrenia.
    Sagud M; Vlatkovic S; Svob Strac D; Sviben M; Zivkovic M; Vilibic M; Vuksan-Cusa B; Mihaljevic-Peles A; Pivac N
    Compr Psychiatry; 2018 Apr; 82():115-120. PubMed ID: 29477703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydrogen sulfide inhibits mitochondrial fission in neuroblastoma N2a cells through the Drp1/ERK1/2 signaling pathway.
    Qiao P; Zhao F; Liu M; Gao D; Zhang H; Yan Y
    Mol Med Rep; 2017 Jul; 16(1):971-977. PubMed ID: 28560384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.
    Krzystanek M; Krupka-Matuszczyk I
    Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex Differences in Antipsychotic Related Metabolic Functioning in Schizophrenia Spectrum Disorders.
    Kraal AZ; Ward KM; Ellingrod VL
    Psychopharmacol Bull; 2017 May; 47(2):8-21. PubMed ID: 28626268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of olanzapine and risperidone on plasma adiponectin levels over time: results from a 3-month prospective open-label study.
    Wampers M; Hanssens L; van Winkel R; Heald A; Collette J; Peuskens J; Reginster JY; Scheen A; De Hert M
    Eur Neuropsychopharmacol; 2012 Jan; 22(1):17-26. PubMed ID: 21511441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between SREBF2 gene polymorphisms and metabolic syndrome in clozapine-treated patients with schizophrenia.
    Yang L; Chen J; Liu D; Yu S; Cong E; Li Y; Wu H; Yue Y; Zuo S; Wang Y; Liang S; Shi Y; Shi S; Xu Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Jan; 56():136-41. PubMed ID: 25201120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and predictors of metabolic syndrome in patients with schizophrenia and healthy controls: A study in rural South Indian population.
    Rawat VS; Ganesh S; Bijjal S; Shanivaram Reddy K; Agarwal V; Devi R; Kumar CN; Christopher R; Thirthalli J
    Schizophr Res; 2018 Feb; 192():102-107. PubMed ID: 28454923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prevalence of metabolic syndrome and its association with alanine aminotransferase in clozapine-treated Korean patients with schizophrenia.
    Lee NY; Roh MS; Kim SH; Jung DC; Yu HY; Sung KH; Chung IW; Youn T; Kang UG; Ahn YM; Kim YS
    Int Clin Psychopharmacol; 2013 Mar; 28(2):71-9. PubMed ID: 23211493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.